1. Home
  2. CRAI vs CRVS Comparison

CRAI vs CRVS Comparison

Compare CRAI & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

N/A

Current Price

$171.55

Market Cap

1.2B

ML Signal

N/A

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$14.59

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRAI
CRVS
Founded
1965
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
1998
2016

Fundamental Metrics

Financial Performance
Metric
CRAI
CRVS
Price
$171.55
$14.59
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$245.00
$30.17
AVG Volume (30 Days)
109.8K
757.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
1.48%
N/A
EPS Growth
20.77
48.04
EPS
8.14
N/A
Revenue
$751,583,000.00
N/A
Revenue This Year
$7.82
N/A
Revenue Next Year
$5.14
N/A
P/E Ratio
$21.57
N/A
Revenue Growth
9.33
N/A
52 Week Low
$132.17
$5.29
52 Week High
$227.29
$26.95

Technical Indicators

Market Signals
Indicator
CRAI
CRVS
Relative Strength Index (RSI) 53.73 51.49
Support Level $170.00 $14.24
Resistance Level $179.62 $16.66
Average True Range (ATR) 6.18 0.70
MACD -0.35 -0.03
Stochastic Oscillator 58.47 56.16

Price Performance

Historical Comparison
CRAI
CRVS

About CRAI CRA International Inc.

CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: